A groundbreaking treatment for one of the most common forms of pancreatic cancer has been approved in pill form by the FDA. The list price runs about $477,000 a year but patients' out-of-pocket costs will vary based on insurance coverage and eligibility for financial assistance.
1.8% ERengagement of this clip — below the author's average (4.53%)
top 27%outperforms 73% of the author's clips
3%of the author's average views
